3Chau I, Joulain F, Iqbal SU, et al. A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRl[J]. BMC Cancer,2014,14:605.
4Hershman DL, Lacchetti C,Dworkin RH,et al. Prevention and management of chemotherapy-induced peripheral neuropathy in.survivors of adult cancers: American Society of Clinical Oncolo-gy clinical practice guideline[J]. J Clin Oncol, 2014,32 (18): 1941-1967.
5Levi F,Misset JL,Brienza S,et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil? folinic acid? and oxali-platin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal canc- er[J]. Cancer,1992,69(4) :893-900.
6Baek KK,Lee J,Park SH,et al. Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancer[J]- Cancer Res Treat,2010,42(4) : 185-190.
7Hoff PM, Saad ED, Costa F, et al. Literature review and prac-tical aspects on the management of oxaliplatin-associated toxic-
Clin Colorectal Cancer,2012,11(2) :93-100.
